Industry News
Life Sciences
Top stories summarized by our editors
8/14/2020

The education and physical safety of millions of adolescent girls were at risk before the COVID-19 pandemic, and governments and nongovernmental organizations must take action to ensure girls can stay in school now, write Michelle Obama and Melinda Gates. "Unless we act, the pandemic could trap a generation of girls in a cycle of poverty -- and shortchange the world of the talents and ideas these girls have to offer," Obama and Gates write.

Full Story:
CNN
8/14/2020

Pfizer's new podcast series "Menopause: Unmuted" features an obstetric gynecologist and real women talking about their experiences. Pfizer is promoting the podcast through social media and on its podcast page.

Full Story:
FiercePharma
8/14/2020

Seb Joseph looks at agency staff cuts during the pandemic and what lies ahead when furloughs and government subsidies come to an end. Restructuring and more flexible working patterns, including an increase in part-time working look likely, but optimism remains, with Uncommon People's Eric Snelleman noting, "Agency bosses are talking to us about making potential hires."

More Summaries:
Seb Joseph
8/14/2020

Kerensa Jimenez, the new CEO of Paragon Health Capital, will lead financing, mergers and acquisitions, as well as capital planning for the life sciences companies in Paragon Biosciences' portfolio. "We have had the privilege of working closely with Kerensa for many years and believe her M&A and capital markets expertise will further enhance our capabilities as we continue on our mission of solving complex human and societal challenges by accelerating development of novel therapies and life science breakthroughs," said Jeff Aronin, chairman, founder and CEO of Paragon Biosciences .

Full Story:
FierceBiotech
8/14/2020

When Halozyme's hyaluronidase enzyme failed to meet clinical trial goals last year, CEO Helen Torley enacted the plan she already had in place to focus on drug delivery and abandon development. Halozyme's revenues have since risen, the company turned a profit in the second quarter, and it is a partner on five drugs on the market -- with more in clinical trials.

Full Story:
FierceBiotech
8/14/2020

Pfizer's Judith Absalon led an early stage clinical trial of BNT162b1, a SARS-CoV-2 vaccine candidate based on messenger RNA that induced a strong immune response that increased with higher doses.

Full Story:
HealthDay News
8/14/2020

Virtual events present opportunities to get noticed, particularly for people who don't thrive in crowds, writes WorldatWork CEO Scott Cawood. He recommends researching speakers, networking and ensuring webcam lighting and background are optimized prior to online conferences, and scheduling time for small talk and staying fully engaged in breakout sessions during conferences.

More Summaries:
WorldAtWork
8/14/2020

Shameze Rampertab has been chosen to serve as chief financial officer and executive vice president of TransEnterix. "I am confident Shameze will make an immediate positive impact on the organization and help lead TransEnterix through its next phase of growth," said CEO Anthony Fernando.

Full Story:
MassDevice (Boston)
More Summaries:
TransEnterix
8/14/2020

The HHS has given a total of $6.5 million to Sonic Healthcare USA and Aegis Sciences to boost their COVID-19 testing capacity by up an additional 4 million per month. The funds will provide the two laboratories with equipment from Thermo Fisher Scientific and Beckman Coulter.

Full Story:
MassDevice (Boston)
8/14/2020

Medtronic plans to invest approximately $1.6 billion in expanding its Hyderabad, India, research and development facility. This will make it the company's second-largest R&D facility.

Full Story:
MassDevice (Boston)